FDA fast-tracks development of two potential COVID-19 vaccines from Pfizer, BioNTech
The U. S. Food and Drug Administration granted fast track designation to two potential COVID-19 vaccines from New York-based Pfizer Inc. and its partner BioNTech SE, based in Germa…